Ticker Scorecard - TBPH Basics Company: Theravance Biopharma, Inc. IPO Date: May 16, 2014 Sector: Healthcare Industry: Biotech Market Cap: $453.02M Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 2.16% Avg Daily Range (30 D): $0.23 | 2.43% Avg Daily Range (90 D): $0.17 | 1.83% Institutional Daily Volume Avg Daily Volume: .34M Avg Daily Volume (30 D): .15M Avg Daily Volume (90 D): .14M Trade Size Avg Trade Size (Sh.): 96 Avg Trade Size (Sh.) (30 D): 56 Avg Trade Size (Sh.) (90 D): 56 Institutional Trades Total Inst.Trades: 2,007 Avg Inst. Trade: $1.4M Avg Inst. Trade (30 D): $.56M Avg Inst. Trade (90 D): $.72M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.16M Avg Closing Trade (30 D): $.59M Avg Closing Trade (90 D): $.78M Avg Closing Volume: 73.95K     News Jun 26, 2024 @ 4:57 PM AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bl... Source: Zacks Equity Research Jun 26, 2024 @ 3:28 PM Here's Why You May Invest in Theravance (TBPH) Sto... Source: Zacks Equity Research Jun 21, 2024 @ 1:55 PM Wall Street Analysts Predict a 90.53% Upside in Th... Source: Zacks Equity Research Jun 12, 2024 @ 3:30 PM Theravance Bio (TBPH) Down 6.1% Since Last Earning... Source: Zacks Equity Research May 14, 2024 @ 4:06 PM Theravance (TBPH) Q1 Earnings Top, Revenues Match ... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.01 $-.26 $-.34 Diluted EPS $-1.01 $-.26 $-.34 Revenue $ 63.19M $ 16.87M $ 14.26M Gross Profit $ $ $ Net Income / Loss $ -49.4M $ -12.7M $ -16.53M Operating Income / Loss $ -43.99M $ -10.84M $ -15.71M Cost of Revenue $ $ $ Net Cash Flow $ -48.31M $ -22.97M $ -7.49M PE Ratio